The Oncology Institute, Inc.
TOI · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $3,401,870 | $1,910,675 | $87,893 | $23,377 |
| - Cash | $27,658 | $30,292 | $39,739 | $49,669 |
| + Debt | $27,356 | $103,551 | $102,306 | $123,152 |
| Enterprise Value | $3,401,568 | $1,983,934 | $150,460 | $96,860 |
| Revenue | $136,564 | $119,802 | $104,406 | $100,267 |
| % Growth | 14% | 14.7% | 4.1% | – |
| Gross Profit | $18,920 | $17,501 | $17,249 | $14,636 |
| % Margin | 13.9% | 14.6% | 16.5% | 14.6% |
| EBITDA | -$12,861 | -$9,406 | -$12,231 | -$10,307 |
| % Margin | -9.4% | -7.9% | -11.7% | -10.3% |
| Net Income | -$16,504 | -$17,009 | -$19,585 | -$13,182 |
| % Margin | -12.1% | -14.2% | -18.8% | -13.1% |
| EPS Diluted | -0.14 | -0.15 | -0.21 | -0.14 |
| % Growth | 6.7% | 28.6% | -50% | – |
| Operating Cash Flow | -$12,630 | -$10,202 | -$4,988 | $4,186 |
| Capital Expenditures | -$604 | -$1,208 | -$328 | -$1,755 |
| Free Cash Flow | -$13,234 | -$11,410 | -$5,316 | $2,431 |